CD44 and neoplasm: Multiple isoforms of CD44 have been implicated in malignant progression across diverse tumor types [7], including colorectal cancers [14], pancreatic cancers [15,16], prostate cancers [17], head and neck squamous cell carcinomas [18], breast cancers [19], and gliomas [20,21].